Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2009-03-06 18:59:16 UTC |
---|
Update Date | 2014-12-24 20:22:27 UTC |
---|
Accession Number | T3D0633 |
---|
Identification |
---|
Common Name | Acridine |
---|
Class | Small Molecule |
---|
Description | Acridine is one of over 100 different polycyclic aromatic hydrocarbons (PAHs). PAHs are chemicals that are formed during the incomplete burning organic substances, such as fossil fuels. They are usually found as a mixture containing two or more of these compounds. (4) |
---|
Compound Type | - Aromatic Hydrocarbon
- Food Toxin
- Natural Compound
- Organic Compound
- Pollutant
- Polycyclic Aromatic Hydrocarbon
|
---|
Chemical Structure | |
---|
Synonyms | Synonym | 10-Azaanthracene | 2,3,5,6-dibenzopyridine | 2,3-Benzoquinoline | 9-Azaanthracene | Aceridine | Acrydine | Benzo(b)quinoline | Benzo[b]quinoline | Dibenzo(b,e)pyridine | Dibenzo[b,e]pyridine |
|
---|
Chemical Formula | C13H9N |
---|
Average Molecular Mass | 179.217 g/mol |
---|
Monoisotopic Mass | 179.073 g/mol |
---|
CAS Registry Number | 260-94-6 |
---|
IUPAC Name | acridine |
---|
Traditional Name | acridine |
---|
SMILES | C1=CC2=CC3=CC=CC=C3N=C2C=C1 |
---|
InChI Identifier | InChI=1S/C13H9N/c1-3-7-12-10(5-1)9-11-6-2-4-8-13(11)14-12/h1-9H |
---|
InChI Key | InChIKey=DZBUGLKDJFMEHC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as acridines. These are organic compounds containing the acridine moiety, a linear tricyclic heterocycle which consists of two benzene rings joined by a pyridine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Quinolines and derivatives |
---|
Sub Class | Benzoquinolines |
---|
Direct Parent | Acridines |
---|
Alternative Parents | |
---|
Substituents | - Acridine
- Benzenoid
- Pyridine
- Heteroaromatic compound
- Azacycle
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | Colorless solid. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | 108°C | Boiling Point | Not Available | Solubility | 0.0384 mg/mL at 25°C [BANWART,WL et al. (1982)] | LogP | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-004i-0900000000-60709f13538ebb5bf03c | 2021-09-24 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 50V, Positive | splash10-0fb9-0900000000-e0c1bf58e0cb2bf829ac | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 40V, Positive | splash10-003r-0900000000-eae554919803e4683fdb | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 30V, Positive | splash10-001i-0900000000-9e670fdb36b28daad5dc | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-001i-0900000000-8173a227a1d988a8e1a0 | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 20V, Positive | splash10-001i-0900000000-422dd5d409aa20c1ff0e | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 35V, Positive | splash10-001i-0900000000-a5b0ca159a9258ef014d | 2021-09-20 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-001i-0900000000-05d700c59ef99ce33b11 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-001i-0900000000-2356d93638ed7ee93521 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-001i-0900000000-11523a8602aa0962e990 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-004i-0900000000-594469afea8b2ce91c8c | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-004i-0900000000-594469afea8b2ce91c8c | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-004i-0900000000-72311cdd3bfe34545a89 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-001i-0900000000-9417270887d6a1e93e91 | 2021-10-12 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-001i-0900000000-9417270887d6a1e93e91 | 2021-10-12 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-001i-0900000000-063b6148248bc2509b93 | 2021-10-12 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-004i-0900000000-8c0deb449c1b4d81b5d9 | 2021-10-12 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-004i-0900000000-8c0deb449c1b4d81b5d9 | 2021-10-12 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-004i-0900000000-8c0deb449c1b4d81b5d9 | 2021-10-12 | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-004i-3900000000-cea0879ccb7e90ce2a83 | 2014-09-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 90 MHz, CDCl3, experimental) | Not Available | 2014-09-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 25.16 MHz, CDCl3, experimental) | Not Available | 2014-09-23 | View Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Oral (4) ; inhalation (4) |
---|
Mechanism of Toxicity | The ability of PAH's to bind to blood proteins such as albumin allows them to be transported throughout the body. Many PAH's induce the expression of cytochrome P450 enzymes, especially CYP1A1, CYP1A2, and CYP1B1, by binding to the aryl hydrocarbon receptor or glycine N-methyltransferase protein. These enzymes metabolize PAH's into their toxic intermediates. The reactive metabolites of PAHs (epoxide intermediates, dihydrodiols, phenols, quinones, and their various combinations) covalently bind to DNA and other cellular macromolecules, initiating mutagenesis and carcinogenesis. (4, 5, 2, 3) |
---|
Metabolism | PAH metabolism occurs in all tissues, usually by cytochrome P-450 and its associated enzymes. PAHs are metabolized into reactive intermediates, which include epoxide intermediates, dihydrodiols, phenols, quinones, and their various combinations. The phenols, quinones, and dihydrodiols can all be conjugated to glucuronides and sulfate esters; the quinones also form glutathione conjugates. (4) |
---|
Toxicity Values | LD50: 400 mg/kg (Subcutaneous, Mouse) (6)
LD50: 500 mg/kg (Oral, Mouse) (6)
LD50: 100 mg/kg (Intravenous, Rabbit) (6) |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not listed by IARC. IARC has evaluated related PAHs (7). |
---|
Uses/Sources | PAHs are released into the environment via the combustion of fossil fuels, coke oven emissions and vehicle exhausts, as well as naturally from forest fires and vocanic eruptions. PAHs from these sources may contaminate nearly water systems. They are also found in coal tar and charbroiled food. (4) |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | PAHs are carcinogens and have been associated with the increased risk of skin, respiratory tract, bladder, stomach, and kidney cancers. They may also cause reproductive effects and depress the immune system. (4) |
---|
Symptoms | Acute exposure to PAHs causes irritation and inflammation of the skin and lung tissue. (1) |
---|
Treatment | There is no know antidote for PAHs. Exposure is usually handled with symptomatic treatment. (4) |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | Not Available |
---|
PubChem Compound ID | 9215 |
---|
ChEMBL ID | CHEMBL39677 |
---|
ChemSpider ID | 8860 |
---|
KEGG ID | C20141 |
---|
UniProt ID | Not Available |
---|
OMIM ID | |
---|
ChEBI ID | 36420 |
---|
BioCyc ID | CPD-10887 |
---|
CTD ID | Not Available |
---|
Stitch ID | Acridine |
---|
PDB ID | Not Available |
---|
ACToR ID | Not Available |
---|
Wikipedia Link | Acridine |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | T3D0633.pdf |
---|
General References | - Santodonato J, Howard P, Basu D: Health and ecological assessment of polynuclear aromatic hydrocarbons. J Environ Pathol Toxicol. 1981 Sep;5(1):1-364. [7310260 ]
- Uno S, Dragin N, Miller ML, Dalton TP, Gonzalez FJ, Nebert DW: Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract. Free Radic Biol Med. 2008 Feb 15;44(4):570-83. Epub 2007 Nov 12. [17997381 ]
- Padros J, Pelletier E: In vivo formation of (+)-anti-benzo[a]pyrene diol-epoxide-plasma albumin adducts in fish. Mar Environ Res. 2000 Jul-Dec;50(1-5):347-51. [11460716 ]
- ATSDR - Agency for Toxic Substances and Disease Registry (1995). Toxicological profile for PAHs. U.S. Public Health Service in collaboration with U.S. Environmental Protection Agency (EPA). [Link]
- Wikipedia. Benzopyrene. Last Updated 22 January 2009. [Link]
- The Physical and Theoretical Chemistry Laboratory of Oxford University (2005). Material Safety Data Sheet (MSDS) for acridine. [Link]
- International Agency for Research on Cancer. 2010. Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures. IARC monograph, volume 92. [Link]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Not Available |
---|
Down-Regulated Genes | Not Available |
---|